Top Articles - Finance

People usually fear what they do not know. You cannot judge or label something until you get to know it.

First impressions are a perfect example. One person may have

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

preconceived notions about somebody who they don’t know much about. Once they get to know that person, they realize that their first impressions were invariably false.

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

The same thing applies with penny stocks. Penny stocks get a bad first impression. They are quickly written off. The purpose of this article is to get past that fi

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

st impression, to really dig deep and see if these bad impressions are warranted or not.

Below are some of the myths that always seem to shadow penny stocks.

Myth

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

#1
“You’ll lose all your money if you trade penny stocks.”

This stems from the belief that trading penny stocks is risky. Actually, any form of investing in

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

tocks will always invariably involve risk. The only way you will lose all your money trading penny stocks is if you don’t bother trying to minimize the risk. T

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

he key is to look to minimize that risk! It’s as simple as that.

For example, starting your own business incurs high risk. Does that stop people from doing it? No.

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

And you know what? The people who succeed in starting their own business are the ones who minimize the risk. They do that by researching on how to successfully start

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

their own business by reading, talking with people and taking action. The same thing applies to penny stocks.

You will not lose all your money by trading penny stocks

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

provided that you minimize your risk by researching, learning, and practicing trading before starting.

Myth #2
“There’s not enough liquidity in penny stock

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

s.”

What do people mean by liquidity? Liquidity simply means having enough volume to easily buy and sell your shares. For example, if a penny stock only has two trad

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

es, its liquidity is said to be low. There are not enough traders to buy and sell.

However, if a stock is experiencing huge amounts of trades, thereby indicating the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

resence of a large number of traders, its liquidity is said to be high because you can easily buy and sell shares.

Looking at an after market report recap of penny sto

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

cks will reflect that there is more than enough liquidity in penny stocks.

Myth #3
“It’s easy to make money in penny stocks.”

When it comes to penny stock

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

, the math looks very appealing. Buy shares at a penny and sell them for two cents. There, you just doubled your money. If it were that easy, people would be million

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

aires.

The fact of the matter is that trading penny stocks can be very rewarding. However, that reward goes to those who educate themselves and paper trade (practice

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

rading with fake money to gain experience), in other words, goes to those who are willing to pay the price to learn.

That’s precisely the reason why some people are ve

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ry negative toward penny stocks. They have been attracted to the potential of making money, only to rush in without any sort of training or education and become disill

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

sioned and embittered.

Despite all the stereotypes that seem to follow penny stocks, there’s one aspect that everyone agrees on. Penny stocks involve high risk and hi

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

gh reward. There’s no doubt about that. The key to getting that high reward is to learn how to minimize the high risk. It’s as simple as that. It’s as simple as that

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/117551/toparticles-Clearing-Up-Myths-About-Penny-Stocks.html">Clearing Up Myths About Penny Stocks</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/117551/toparticles-Clearing-Up-Myths-About-Penny-Stocks.html]Clearing Up Myths About Penny Stocks[/url]

Have you always dreamed of having your own home business but didn't feel you would have the time or money to invest? Here are some great home remedies to help you save time while earning a lucrative Internet income from home...

Is being first to market really that important? I believe that the amount of energy and time purporting this myth is somewhat unnerving in that being first to market is not always so great. Indeed, I have been first to market many times and yes, no one can deny that often that is a total advantage. But it is also somewhat costly to chase hunches and the cost to build a prototype that crashes and burns is not so funny, especially when the future of your company hangs in the balance.

Can money be made with affiliate programs. The answer is...Yes, if you pick an honest and ethical one. You also want to associate yourself with one that gives you a decent commission, 50% and above. Most good programs offer support including prewritten ads for you to promote.

Tags

Links

Top Articles - Clearing Up Myths About Penny Stocks

Related Articles: